In vitro activities of five quinolones against Chlamydia pneumoniae
- 1 March 1992
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (3) , 682-683
- https://doi.org/10.1128/aac.36.3.682
Abstract
The in vitro susceptibilities of 10 strains of Chlamydia pneumoniae were determined for five quinolones, including ciprofloxacin, ofloxacin, fleroxacin, temafloxacin, and sparfloxacin. Sparfloxacin was the most active compound tested, followed by ofloxacin and temafloxacin. Ciprofloxacin and fleroxacin were the least active. The use of HEp-2 cells for testing C. pneumoniae resulted in larger inclusions but essentially the same endpoints as were seen with use of HeLa 229 cells.Keywords
This publication has 8 references indexed in Scilit:
- Persistent Infection with Chlamydia pneumoniae following Acute Respiratory IllnessClinical Infectious Diseases, 1992
- Infection with Chlamydia pneumoniae in BrooklynThe Journal of Infectious Diseases, 1991
- Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infectionsThe American Journal of Medicine, 1990
- In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogensAntimicrobial Agents and Chemotherapy, 1990
- A New Respiratory Tract Pathogen: Chlamydia pneumoniae Strain TWARThe Journal of Infectious Diseases, 1990
- In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR)Antimicrobial Agents and Chemotherapy, 1989
- Tissue Penetration of the New Quinolones in HumansClinical Infectious Diseases, 1989
- Susceptibility testing of Chlamydia trachomatis: from eggs to monoclonal antibodiesAntimicrobial Agents and Chemotherapy, 1988